Clinical Trials

Current Clinical Trials

UCD0305: Longitudinal study of the relationship between impairment, activity limitation, participation and quality of life in persons with confirmed Duchenne Muscular Dystrophy

NIFD: National Initiative for Families with Duchenne

Upcoming Clinical Trials

There are no upcoming trials planned to begin in 2008

Completed Clinical Trials

CNMC0601: Prednisone High Dose vs. Daily in Duchenne Muscular Dystrophy

CNMC0705: A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy

PITT0503: Clinical Trial of CoenzymeQ10 and Prednisone in Duchenne Muscular Dystrophy

CNMC0599: A multicenter randomized placebo-controlled double-blind study to assess the efficacy and safety of glutamine and creatine monohydrate in Duchenne muscular dystrophy

CNMC0301: An open-label pilot study of Coenzyme Q10 in steroid-treated Duchenne muscular dystrophy

KUL0401: An open-label pilot study of oxatomide in steroid-naive Duchenne muscular

Click here for more information on clinical trials.



CINRG Research Group was formed as the clinical research arm of the Duchenne Muscular Dystrophy Research Center
(DMD Research Center) and the Research Center for Genetic Medicine at the Children’s National Medical Center (CNMC).
CINRG is dedicated to muscular dystrophy research. The CINRG Coordinating Center is located in the Children’s Research
Institute on the 5th floor of CNMC in Washington, DC. Web Design by Blue Water Media